Article
ForHumanityPublished

Testosterone replacement therapy (TRT), like any medical treatment, can cause side effects. Many are mild and manageable, while others are important to monitor because they may signal that your treatment needs to be adjusted. A small number of symptoms require prompt medical attention.
Knowing what to expect—and what to tell your provider—is an important part of using TRT safely.
Some side effects can occur after starting TRT and may be mild or manageable with appropriate treatment and monitoring.
Not everyone experiences these effects, and the type of side effects you experience can also depend on the testosterone formulation you use.
Some effects of TRT may not cause obvious symptoms at all. This is one reason follow-up visits and laboratory testing are an important part of treatment.
Elevated hematocrit. Testosterone can stimulate red blood cell production and increase hematocrit. For this reason, hematocrit is checked before treatment and monitored after TRT begins. Current clinical guidelines recommend intervention if hematocrit rises above 54%, including evaluating possible contributing factors such as hypoxia or sleep apnea and adjusting treatment as appropriate.
Changes in PSA. For men undergoing prostate monitoring, PSA is assessed before and after testosterone therapy according to age, individual risk, and shared decision-making. A significant increase does not automatically mean prostate cancer, but it may warrant further evaluation.
Breast tenderness or enlargement. Testosterone can be converted to estradiol in the body, and some men may develop breast tenderness or gynecomastia during treatment. If this occurs, tell your provider so the cause can be evaluated rather than trying to adjust your hormones on your own.
Worsening sleep apnea. Untreated severe obstructive sleep apnea is an important consideration when starting testosterone therapy, and sleep-related symptoms should not be ignored. If you develop or notice worsening loud snoring, witnessed pauses in breathing, morning headaches, or excessive daytime sleepiness, tell your provider.
Blood pressure changes. Testosterone can increase blood pressure in some men. In 2025, the FDA required blood-pressure warnings across testosterone products after ambulatory blood-pressure studies demonstrated increases with testosterone treatment. If you are receiving TRT through telehealth, your provider may recommend monitoring your blood pressure at home or having it checked periodically as part of your routine medical care.
Some symptoms should not be assumed to be a normal effect of TRT.
Seek prompt medical evaluation for symptoms such as new or severe shortness of breath, significant one-sided leg swelling or pain, or difficulty urinating. Symptoms that could indicate a medical emergency—including chest pain, sudden severe shortness of breath, sudden weakness or numbness on one side of the body, difficulty speaking, or signs of a severe allergic reaction—require immediate emergency care.
These symptoms can have many causes and do not necessarily mean TRT is responsible. What matters is that potentially serious symptoms are evaluated rather than attributed to a normal adjustment to treatment.
Do not change your dose or treatment schedule on your own because of a side effect. Contact your provider so the symptom and your treatment can be evaluated appropriately.
Questions about cardiovascular risk have surrounded testosterone therapy for years.
The 2023 TRAVERSE trial studied more than 5,000 men with hypogonadism who had preexisting cardiovascular disease or were at increased cardiovascular risk. Testosterone therapy was not associated with an increased incidence of the study's primary endpoint of major adverse cardiovascular events—cardiovascular death, nonfatal heart attack, or nonfatal stroke—compared with placebo.
However, the study also found a higher incidence of atrial fibrillation, acute kidney injury, and pulmonary embolism in the testosterone group. These findings are part of the broader risk-benefit discussion clinicians consider when prescribing and monitoring testosterone therapy.
Following its review of TRAVERSE and other required studies, the FDA removed the boxed warning regarding increased cardiovascular risk from testosterone product labeling in 2025. At the same time, the agency required warnings about increased blood pressure for testosterone products.
Your individual cardiovascular history and risk factors still matter and should be discussed with your provider before and during treatment.
Managing TRT involves more than checking a testosterone number.
Your provider evaluates how you are feeling alongside your laboratory results and other relevant health information. Monitoring commonly includes testosterone and hematocrit, while PSA and other testing may be appropriate depending on your age, medical history, symptoms, and individual risk factors.
If a side effect develops, the answer is not automatically to stop treatment or add another medication. Your provider may first look at your dose, dosing frequency, testosterone level, other laboratory findings, medical conditions, medications, and other possible causes of the symptom.
The goal is to use the information together to determine whether treatment should stay the same or whether something needs to change.
What are some common side effects of TRT?
Possible side effects include acne or oily skin, fluid retention, injection-site reactions with injectable testosterone, changes in red blood cell production, and suppression of sperm production. Not everyone experiences the same effects, and some are specific to the type of testosterone being used.
Why is hematocrit monitored on TRT?
Testosterone can increase red blood cell production and raise hematocrit. Because a substantial increase may require a change in treatment, hematocrit is measured before TRT and periodically after treatment begins.
Does TRT increase the risk of a heart attack or stroke?
The large TRAVERSE trial found that testosterone therapy did not increase the incidence of major adverse cardiovascular events compared with placebo in men with hypogonadism who had preexisting cardiovascular disease or were at increased cardiovascular risk. However, pulmonary embolism, atrial fibrillation, and acute kidney injury occurred more frequently in the testosterone group, so individual risks still matter.
When should I call my provider instead of waiting for my next appointment?
Contact your provider if you develop a new or persistent side effect, significant swelling, breast tenderness or enlargement, worsening sleep symptoms, urinary problems, or other symptoms that concern you. Seek emergency medical care for symptoms such as chest pain, sudden severe shortness of breath, sudden one-sided weakness or numbness, difficulty speaking, or signs of a severe allergic reaction.
This article is for educational purposes only and is not medical advice. Testosterone therapy is available by prescription following clinical evaluation. Always consult a licensed clinician about your individual symptoms and treatment.
ADD